Zymeworks ZYME Issue of shares upon vesting of restricted stock units (in shares)

Issue of shares upon vesting of restricted stock units (in shares) at other companies

ZymeworksZYME

72.8K—

Boston BeerSAM

46.9K+43.0%

Affiliated Managers GroupAMG

$34.38M+20.2%

ZymeworksZYME

$0—

Deckers Outdoor CorporationDECK

$2.28M+5.3%

HTF

Heartflow, Inc. Common StockHTFL

-$473K-271%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's issue of shares upon vesting of restricted stock units (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's issue of shares upon vesting of restricted stock units (in shares)?: Zymeworks (ZYME) reported issue of shares upon vesting of restricted stock units (in shares) of 72.8K in Q4 2025.
What does issue of shares upon vesting of restricted stock units (in shares) mean?: The total number of shares issued to employees upon the vesting of restricted stock units. This reflects the actual dilution impact on existing shareholders resulting from the settlement of equity-based compensation awards.